Login to Your Account

Earnings Roundup

Monday, January 23, 2012
• Cubist Pharmaceuticals Inc., of Lexington, Mass., reported full-year 2011 revenues of $754 million and GAAP earnings of $33 million, or 52 cents per diluted share. For the fourth quarter, revenues of $213 million beat the $204 million analysts had expected, but GAAP earnings of $6.8 million, or 11 cents per share, were far below expectations because of Cubist's $415 million acquisition of Exton, Pa.-based Adolor Corp.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription